The ASCO Annual Meeting is being held June 2 to 6, and here is some of the notable research that will be presented today. This research explores using less extensive surgery for cervical cancer and using targeted therapy to reduce the risk of breast cancer recurrence. Read More >>
research
June 2, 2023 · ASCO Staff
May 30, 2023 · Jyoti Patel, MD, FASCO
In this month’s “From the Editor in Chief” column, Dr. Jyoti Patel discusses why more cancer research is being done about de-escalation treatment, including how these types of studies help doctors personalize treatment plans for each patient. Read More >>
May 25, 2023 · ASCO Staff
The ASCO Annual Meeting is being held June 2 to 6, and here is some of the notable research that will be presented today. Topics include treatment for anemia related to myelodysplastic syndromes, pembrolizumab for advanced cervical cancer, surgery options for early pancreatic cancer, weight loss in breast cancer survivorship, the effect of Medicare expansion on racial disparities, and collaborating across borders to help children with leukemia. Read More >>
April 19, 2023 · Greg Guthrie, ASCO staff
Read about 2 studies from the April 2023 ASCO Plenary Series, which highlights the use of adagrasib to target several solid tumors with a KRAS G12C mutation and the use of toripalimab to treat stage III non-small cell lung cancer before and after surgery. Read More >>
March 21, 2023 · Brielle Gregory Collins, ASCO staff
Read research from the March 2023 session of the ASCO Plenary Series, which highlights a study evaluating a new targeted therapy drug given in combination with chemotherapy for people with advanced gastric or gastroesophageal junction cancer. Read More >>
Pages
- 1 current page
- page 2
- page 3
- page 4
- page 5
- page 6
- page 7
- page 8
- page 9
- …
- next page ›
- last page »